NACYSTELYN clinical trials

A double blind, placebo controlled, parallel, study to evaluate the effects of NAL in Obstructive Sleep Apnea Patients.

This study is looking into a new medication called NACYSTELYN for people with sleep apnoea. It wants to see if this medicine can help reduce how many times breathing stops or gets very shallow during sleep, compared to a dummy medicine.